Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

ONCOLife

Rewiring RNA: Antisense RNA Therapy Exposes a New Weakness in Pancreatic Cancer

Clinical Trials

TRBC2-Specific ADC Shows Robust Efficacy in T-Cell Lymphomas and Leukemias

ONCOLife

Engineered Oncolytic Virus Reprograms Immunity and Extends Survival in Brain Cancer

Clinical Trials

Less Toxic, More Effective: RW Evidence Supports Reduced Immunotherapy Dose in Melanoma

AI

Artificial Intelligence Detects Pancreatic Cancer More Accurately Than Radiologists

ONCOLife

Colibactin’s Molecular Blueprint Exposes How a Gut Microbial Toxin Triggers Colorectal Cancer

ONCOLife

Blood-Based cfDNA Test Demonstrates Potential for Detecting Lung Cancer in Nonsmokers

ONCOLife

Nanotherapy Reprograms Glioblastoma Immunity Through Nose-to-Brain Delivery

Biotech

Lung Organoids Offer a Revolutionary Path to Transform Drug Testing and Cancer Therapies

ONCOLife Issues

Featured Articles

Amivantamab Plus Chemotherapy Shows Promising Long-Term Responses in Colorectal Cancer

11 January 2026

Longer-term follow-up from the Phase 1b/2 OrigAMI-1 study shows that amivantamab (Rybrevant) plus FOLFOX or FOLFIRI achieved a 51 percent overall response rate in RAS/BRAF wild-type metastatic colorectal cancer, rising to 73 percent in first-line patients....

Trending Articles

Lenvatinib Plus Everolimus Improves Outcomes After PD-1 Failure in Kidney Cancer

Novartis Invests $23 Billion to Boost Radioligand Manufacturing Capacity in Carlsbad

Pharma

11 November 2025

Ribociclib Extends Disease-Free Survival Beyond Treatment in HR+/HER2– Early Breast Cancer

ONCOLife

3 November 2025

DeLLphi-303: Tarlatamab Plus Chemo Achieves 71% Response in ES Small-Cell Lung Cancer

ONCOLife

4 November 2025

ctDNA Blood Test Guides Chemotherapy Decisions for Tailored Colon Cancer Treatment

ONCOLife

4 November 2025

Trodelvy Emerges as Potential New Standard for First-Line Metastatic TN Breast Cancer

ESMO’s Road Map for Safe and Effective Use of AI-LLMs in Cancer Care: 23 Rules from 20 Experts

AI

3 November 2025

Datroway Extends Survival by 5 Months in Metastatic Triple-Negative Breast Cancer

ONCOLife

21 October 2025

AI Analysis of Thymic Health Predicts Immunotherapy Success, Cutting Death Risk by 44%

ONCOLife

18 October 2025

Lenvatinib Plus Pembrolizumab Delivers Durable 5-Year Survival in Endometrial Carcinoma

ONCOLife

20 October 2025

Disarming Prostate Cancer: Dual Enzyme Blockade Weakens Tumors and Boosts Drug Response

Molecular Trojan Horse: Peptide Nanotubes Offer a Path to Defeat Drug-Resistant Tumors

ONCOLife

13 October 2025

Reprogramming Cancer Cell Death: A New Immune-Based Strategy for Blood Cancers

ONCOLife

12 October 2025

LED-Activated SnOx Nanoflake Therapy Destroy Tumor Cells with Precision

ONCOLife

11 October 2025

In Vivo CAR T on the Horizon: BMS Acquires Orbital to Expand Cell Therapy Reach

Pharma

10 October 2025